Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | REN | P00797 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8651989 | 1.00 | ALDH1A1 (0.55) | ALDH1A1EPHX1CA12CA1CA2 | |
| SCHEMBL6808670 | 1.00 | ALDH1A1 (0.55) | ALDH1A1EPHX1CA12CA1CA2 | |
| SCHEMBL5967438 | 0.89 | — | — | |
| SCHEMBL4623975 | 0.85 | ALDH1A1 (0.42) | ALDH1A1EPHX1CA12CA1CA2 | |
| SCHEMBL6769503 | 0.84 | ALDH1A1 (0.42) | ALDH1A1EPHX1CA12CA1CA2 | |
| SCHEMBL6559712 | 0.83 | ALDH1A1 (0.37) | ALDH1A1RENACESMN1; SMN2 | |
| SCHEMBL4742218 | 0.83 | ALDH1A1 (0.42) | ALDH1A1EPHX1CA12CA1CA2 | |
| SCHEMBL17715691 | 0.83 | ALDH1A1 (0.42) | ALDH1A1EPHX1CA12CA1CA2 | |
| SCHEMBL27474754 | 0.81 | ALDH1A1 (0.50) | ALDH1A1EPHX1SMN1; SMN2 | |
| SCHEMBL13999779 | 0.81 | EPHX1 (0.48) | ALDH1A1EPHX1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117960247-A | Fast detection method of recessive malachite green based on nano enzyme oxidation and preparation method of nano enzyme | 郑州大学 | 2024-05-03 | — | — | CN | claimed |
| CN-117286533-A | Preparation method of sulfur-nitrogen coordinated zinc-manganese diatomic catalyst loaded on eggshell structure carbon-based carrier | 北京理工大学 | 2023-12-26 | — | — | CN | claimed |
| CN-116328808-A | Three-dimensional ordered porous Fe-NC catalyst and preparation method and application thereof | 南京理工大学 | 2023-06-27 | — | — | CN | claimed |
| CN-110219003-B | Etching solution for etching metal layer composed of copper layer and molybdenum layer and application thereof | 江苏和达电子科技有限公司 | 2021-08-24 | — | — | CN | claimed |
| CN-111228155-A | Pet shampoo capable of lasting fragrance and preparation method thereof | 广州乐宠宠物用品有限公司 | 2020-06-05 | — | — | CN | claimed |
| CN-110498904-A | Expediting setting type epoxy systems | EVONIK DEGUSSA GMBH | 2019-11-26 | — | — | CN | claimed |
| CN-110498905-A | Expediting setting type epoxy systems | EVONIK DEGUSSA GMBH | 2019-11-26 | — | — | CN | claimed |
| CN-110219003-A | For etching the etching solution and its application of the metal layer being made of layers of copper and molybdenum layer | 江苏和达电子科技有限公司 | 2019-09-10 | — | — | CN | claimed |
| EP-3068860-B1 | MULTI-CAPSULE COMPOSITIONS | INT FLAVORS & FRAGRANCES INC (US) | 2019-08-21 | — | — | EP | claimed |
| CN-108745285-A | The preparation method of the magnetic porous carbon adsorbing material of antibiotic in a kind of adsorbed water body | 盐城工学院 | 2018-11-06 | — | — | CN | claimed |
| EP-1447102-B1 | Cyclohexylethan-1-yl ester mixtures as malodour counteractants and methods for using same | INT FLAVORS & FRAGRANCES INC (US) | 2008-06-04 | — | — | EP | claimed |
| US-20080103155-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | SPROUT PHARMACEUTICALS, INC. | 2008-05-01 | — | — | US | claimed |
| EP-1167507-B1 | Malodor counteractant compositions and methods for preparing and using same | BUSH BOAKE ALLEN INC (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1740181-A1 | NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-10 | — | — | EP | claimed |
| US-20050245539-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | US | claimed |
| WO-2005102342-A1 | NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | WO | claimed |
| US-20040044080-A1 | Treatment of dyspareunia with topically administered nitroglycerin formulations | VIVUS, INC. | 2004-03-04 | — | — | US | claimed |
| US-6432891-B1 | INTRODUCING INTO SOLID OR LIQUID, SOAP OR DETERGENT COMPOUND SELECTED FROM 1-CYCLOHEXYL-ETHYLBUTYRATE, 1-CYCLOHEXYL-ETHYLACETATE, 1-CYCLOHEXYL-ETHANOL, 4-ISOPROPYL-CYCLOHEXYLPROPIONATE | BUSH BOAKE ALLEN INC., | 2002-08-13 | — | — | US | claimed |
| US-20020032131-A1 | Malodor counteractant compositions and methods for preparing and using same | BUSH BOAKE ALLEN INC. | 2002-03-14 | — | — | US | claimed |
| EP-1167507-A2 | Malodor counteractant compositions and methods for preparing and using same | Bush Boake Allen Inc. (US) | 2002-01-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103155-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | FLNB, FLNA, FGB | ALDH1A1 948/4885EPHX1 1382/4885CA12 3751/4885 |
| US-20040044080-A1 | Treatment of dyspareunia with topically administered nitroglycerin formulations | PDE12, PDE3A, PDE2A | ALDH1A1 2128/4885EPHX1 1961/4885CA12 2742/4885 |
| US-20050245539-A1 | Pharmaceutical compositions for the treatment of sexual disorders II | FLNB, FLNA, FGB | ALDH1A1 948/4885EPHX1 1382/4885CA12 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.